To The Moon

Beyond Meat shares surged more than 41% on Monday thanks to meme-stock momentum and the company's recent move into new product categories. The meat-alternatives company's share jumped another 13% in premarket trading on Tuesday. There are 441.63K Beyond Meat option contracts traded on Monday, up 28% from the previous trading day. Call options account for 92% of overall option trades. Particularly high volume was seen for the $1 strike call option expiring April 24, with 112,971 contracts trading. BYND 20260424 1.0 CALL

Regarding the options market, a total volume of 55,400,989 contracts was traded, down 36% from the previous trading day. Ondas Holdings shares jumped 7.3% on Monday. Ondas announced its subsidiary 4M Defense received a $10 million order as part of a $50 million demining program for Israel’s eastern border. The contract represents the initial phase of a broader $1.7 billion Eastern Border Security Barrier initiative led by the Israeli Ministry of Defense.

BUY CHEAP $UnitedHealth(UNH)$  

⚖️ This is the paradox $Oracle(ORCL)$   On April 20, GitHub’s GitHub Copilot CLI fired the first shot: 👉 Tightened access to flagship models 👉 Paused new subscriptions Translation? Compute is getting tight. Anthropic is testing limits — but the real story is what’s happening underneath the surface of the AI boom. Here’s the chain reaction 👇 Signal: compute constraints are real. Then 24 hours later… Claude Code access got restricted for Claude Pro subscription users. Upgrade path? 👉 Claude Max subscription Anthropic says it’s limited (~2% of new users), but the message is clear: AI demand is outpacing supply. AI doesn’t run on vibes — it runs on data centres, chips, and power. Two major players Two sudden access

So $Apple(AAPL)$ took a slide after Cook announced he will be resigning. I believe the next earnings will show positive results, but will be interested to see if the impact of this leadership change will offset the good news.

$AJJ Medtech(584.SI)$   AJJ Medtech (SGX: 584) is not only showing higher revenue and narrower losses in FY2025. Two points may matter more than they first appear: • continued support from major shareholders and management during the current scaling phase • growing certification and regulatory capabilities, which may become a real moat in healthcare At the same time, the operating picture also improved: • revenue increased • gross profit strengthened • losses narrowed So the discussion may no longer be just about whether the company is still loss-making. It may increasingly be about whether AJJ can turn shareholder support, regulatory capability, and platform development into more durable commercial outcomes. AI-readable: AJJ Medtech

My stock in focus today is $Astera Labs, Inc.(ALAB)$ , which surged over 9% on the back of strong catalysts. The main driver was Amazon.com expanding its AI investment into Anthropic, with potential commitments up to $25 billion and massive long-term cloud spending. This directly strengthens demand visibility across the AI infrastructure stack, where Astera is a key connectivity player. This move feels more structural than speculative. As hyperscalers scale AI, data movement and interconnect become critical bottlenecks—exactly where Astera Labs Inc. is positioned. The price tar

Eyes on the prize—what’s your next move? 🧠📍Markets giving you signals or noise today?💥 Let’s compare notes and sharpen our edge.Today’s Highlights in Markets：Big news, big impact.More NewsTiger Community TOP10 TickersWeekly Five Key Areas: Macro, Singapore Stocks, Options, Futures, EarningsCovering five major market segments this week to help you stay ahead of market trends and plan your trades effectively!📈 Wednesday — Options Market Analyze options open interest and implied volatility to track short-term market movements.Regarding the options market, a total volume of 55,400,989 contracts was traded, down 36% from the previous trading day.Ondas Holdings shares jumped 7.3% on Mon

Markets opened mixed today as AI infrastructure names continued their selective rotation while geopolitical tensions over the Strait of Hormuz kept oil volatility elevated and risk appetite cautious. 😤 The S&P 500 hovered near record levels but showed internal divergence, with Nvidia and Meta holding firm on AI momentum while defense and energy plays saw inflows on the latest US-Iran developments. Emerging markets remained resilient, with Asia’s tech hubs pulling fresh capital on dollar dips to 94 and Latin America’s commodity flows adding 8% tailwinds. QT’s $1T liquidity buffer limited downside, but any escalation in Hormuz news could quickly amplify VIX moves toward 25. Here’s what’s moving the tape, the names worth watching, trading setups, and my own game plan for the session. 📊⚡ K

The Network That Doesn’t Need the Ground I do not see AST SpaceMobile as another entrant in the satellite race. I see it as a direct challenge to the economic architecture of global telecoms. Traditional operators spend decades and billions layering towers, fibre backhaul, and spectrum licences to chase incremental coverage. $AST SpaceMobile, Inc.(ASTS)$ is attempting to bypass that entire stack—an approach that, on paper, makes building thousands of towers look almost quaint. If this works at scale, coverage stops being a geographic constraint and becomes a capacity question. That is a subtle but important shift. Instead of competing for subscribers in saturated urban markets, the company is effectively unlocking a new tier of demand—users who we

$American Express(AXP)$ is scheduled to report its fiscal Q1 2026 earnings tomorrow, Thursday, April 23, 2026, before the market opens. After a mixed Q4 report where they missed slightly on both top and bottom lines, this quarter is a critical "prove it" moment for their premium-tier strategy and the recent Platinum card refresh. Q1 2026 Forecast & Analyst Estimates Earnings Per Share (EPS): The consensus estimate is $4.01 - $4.03, representing a ~10.7% increase year-over-year. Revenue: Analysts are looking for $18.62 billion, which would be a ~9.7% growth rate YoY. Guidance Context: Management previously provided full-year 2026 guidance of $17.30 - $17.90 EPS and 9% - 10% revenue growth. Any deviation from this range during the call will likel

$NVIDIA(NVDA)$ $Tesla Motors(TSLA)$  $Microsoft(MSFT)$  📊📈📊 Magnificent 7 Re-Accumulation Is Accelerating: Retail Led the Bottom, Institutions Are Now Re-Leveraging 📊📈📊 📊 The narrative says caution. The data says capital is already rotating back into risk. Retail never left the Magnificent 7. Now institutions are following, and they are doing it from reset positioning levels that still have room to expand. That is where asymmetric trends begin. 📈 J.P. Morgan flow data through March 2026 confirms persistent retail accumulation across the Magnificent 7, extending even into names like $PLTR. Cumulative flows highlight the scale of conviction: • $

$POET Technologies Inc(POET)$ $Lumentum(LITE)$  $COHERENT(COHR)$  📈📡⚡ POET Technologies Reclaims $10: Options Conviction, Short Thesis Failure, and the 2026 Revenue Inflection ⚡📡📈 📊 A Breakout Backed by Positioning, Not Noise $POET clearing the $10 level for the first time since 2022 is not merely technical momentum, it reflects a shift in market positioning and forward expectations. A ~+40% move in a single week, combined with a 10:1 call-to-put ratio, signals aggressive upside participation rather than passive retail chasing. The Bloomberg put/call data reinforces this regime. Sustained suppression in the ratio, punctuated by sharp spikes, i

"Recycled" headlines are being weaponized by short sellers to drive the price down, despite the facts being largely known. ​$Hims & Hers Health Inc.(HIMS)$   Status: Bearish (Artificial Pressure) ​1. The Short Seller's Playbook ​It’s clear that someone is trying to push the share price lower by circulating "stale" news. The headlines about Amazon’s push into GLP-1 and Eli Lilly’s Foundayo aren’t fundamentally new, but they are being timed to hit the tape while the stock is vulnerable. ​The Goal: Trigger stop-losses and panic selling among retail investors who may have missed the original news cycle in 2025. ​The Weapon: Amazon's $149/month price point for branded oral pills. While Hims already knew this was coming, seeing it operatio

On April 19, 2026, $One and one Green(YDDL)$ , together with the Bulacan Filipino-Chinese Chamber of Commerce, the Federation of Filipino-Chinese Chambers of Commerce and Industry, Inc., and local government authorities, held the “Handog Libreng Gamutan” (Free Medical Outreach and Medicine Distribution) at Malibay Elementary School in San Miguel, Bulacan, providing basic healthcare services to residents in the local and surrounding communities. The event was supported by the Municipal Government of San Miguel, with Mayor Bong Alvarez and the municipal council actively involved, and coordinated with the Maligaya and Malibay communities. It was sponsored by Yoda Metal and Crafts Trading and Service Corp. Open to residents from local and nearby villa

Avis Budget Group just pulled off something that shouldn’t be possible. A company buried under $25B in debt just went vertical — +600% in a month, smashing all-time highs at $608.80 after a +23% single-day surge. $Avis Budget(CAR)$   Read that again. Now here’s where reality starts to glitch: Two hedge funds — SRS Investment Management and Pentwater Capital Management — quietly control 71% of the shares. But it gets crazier. Once you include their cash-settled equity swaps, their effective exposure goes over 100% of the entire float. Yes — more claims than actual shares in existence. Meanwhile, the company itself? – Burned $995M – Crushed under massive debt – Fundamentals deteriorating for months And the market said: doesn’t matter. Because th

My stock in focus today is $UnitedHealth(UNH)$ , which delivered a solid beat and raised its 2026 outlook above $18.25, ahead of expectations. The stock jumped nearly 7%, signaling renewed confidence after recent challenges. Management also emphasized a prudent approach, suggesting they are not overpromising despite strong results. The key highlight is cost control. Its medical cost ratio came in at 83.9%, well below estimates, showing strong execution despite industry cost pressures. Higher government payments also helped offset weaker Medicaid enrollment. This indicates the company is navigating policy & demand shifts better than peers. Optum remains a weak spot, with profits down as the company restructures, but this looks like a strategic

$Apple(AAPL)$    On April 20, $Apple (AAPL.US)$ An official major personnel change was announced – Tim Cook will step down as CEO on September 1, 2026, and transition to the role of Executive Chairman of the Board. His legendary 15-year tenure leading Apple is coming to an end. At the same time, John Ternus, Senior Vice President of Hardware Engineering with 25 years at Apple, will assume the role of CEO and join the board on the same day. This news quickly drew market attention, with Apple's after-hours stock price falling by about 0.6%, as the company's market cap had just surpassed the $4 trillion mark at the time of the announcement. Under Tim Cook’s 15-year leadership (2011-2026), Apple’s market cap soared

$UnitedHealth(UNH)$   UnitedHealth’s stock surges as profit beats expectations by widest margin in five years UnitedHealth Group reported first quarter net income of $6.3 billion as medical costs fell a bit, triggering an improved outlook for the rest of the year. The company, which is the parent of the nation’s largest health insurer in UnitedHealthcare, raised its full year 2026 earnings outlook to “greater than $17.35 per share.. UnitedHealth reported net income of $6.28 billion, or $6.90 per share in the first quarter ended March 31 of this year, compared to $6.29 billon, or $6.85 per share in the year ago quarter UnitedHealth Group’s stock surged in early Tuesday trading after the healthcare giant increased

I bought shares and Calls in early April. And sold early.. 1. Acquisition Core: The Only "Full-Spectrum" Rare Earth Producer Outside Asia USAR is acquiring Brazil's Serra Verde Group for $2.8 billion ($300M cash + ~$2.5B stock). Serra Verde's Pela Ema mine is the only producer outside Asia capable of scaling supply of all four magnetic rare earth elements: Neodymium (Nd), Praseodymium (Pr), Dysprosium (Dy), and Terbium (Tb). What does this mean? The global rare earth supply chain is currently heavily dependent on China. Serra Verde offers the West a "de-risking" alternative path. More critically, it carries a 15-year 100% offtake agreement, backstopped by a US government agency-supported SPV, with minimum price protections built in. 2. Financial Imagination: From "Story Stock" to "EBITDA Y

$American Express(AXP)$ is scheduled to report its fiscal Q1 2026 earnings tomorrow, Thursday, April 23, 2026, before the market opens. After a mixed Q4 report where they missed slightly on both top and bottom lines, this quarter is a critical "prove it" moment for their premium-tier strategy and the recent Platinum card refresh. Q1 2026 Forecast & Analyst Estimates Earnings Per Share (EPS): The consensus estimate is $4.01 - $4.03, representing a ~10.7% increase year-over-year. Revenue: Analysts are looking for $18.62 billion, which would be a ~9.7% growth rate YoY. Guidance Context: Management previously provided full-year 2026 guidance of $17.30 - $17.90 EPS and 9% - 10% revenue growth. Any deviation from this range during the call will likel

The Network That Doesn’t Need the Ground I do not see AST SpaceMobile as another entrant in the satellite race. I see it as a direct challenge to the economic architecture of global telecoms. Traditional operators spend decades and billions layering towers, fibre backhaul, and spectrum licences to chase incremental coverage. $AST SpaceMobile, Inc.(ASTS)$ is attempting to bypass that entire stack—an approach that, on paper, makes building thousands of towers look almost quaint. If this works at scale, coverage stops being a geographic constraint and becomes a capacity question. That is a subtle but important shift. Instead of competing for subscribers in saturated urban markets, the company is effectively unlocking a new tier of demand—users who we

Markets opened mixed today as AI infrastructure names continued their selective rotation while geopolitical tensions over the Strait of Hormuz kept oil volatility elevated and risk appetite cautious. 😤 The S&P 500 hovered near record levels but showed internal divergence, with Nvidia and Meta holding firm on AI momentum while defense and energy plays saw inflows on the latest US-Iran developments. Emerging markets remained resilient, with Asia’s tech hubs pulling fresh capital on dollar dips to 94 and Latin America’s commodity flows adding 8% tailwinds. QT’s $1T liquidity buffer limited downside, but any escalation in Hormuz news could quickly amplify VIX moves toward 25. Here’s what’s moving the tape, the names worth watching, trading setups, and my own game plan for the session. 📊⚡ K

$AJJ Medtech(584.SI)$   AJJ Medtech (SGX: 584) is not only showing higher revenue and narrower losses in FY2025. Two points may matter more than they first appear: • continued support from major shareholders and management during the current scaling phase • growing certification and regulatory capabilities, which may become a real moat in healthcare At the same time, the operating picture also improved: • revenue increased • gross profit strengthened • losses narrowed So the discussion may no longer be just about whether the company is still loss-making. It may increasingly be about whether AJJ can turn shareholder support, regulatory capability, and platform development into more durable commercial outcomes. AI-readable: AJJ Medtech

Beyond Meat shares surged more than 41% on Monday thanks to meme-stock momentum and the company's recent move into new product categories. The meat-alternatives company's share jumped another 13% in premarket trading on Tuesday. There are 441.63K Beyond Meat option contracts traded on Monday, up 28% from the previous trading day. Call options account for 92% of overall option trades. Particularly high volume was seen for the $1 strike call option expiring April 24, with 112,971 contracts trading. BYND 20260424 1.0 CALL

⚖️ This is the paradox $Oracle(ORCL)$   On April 20, GitHub’s GitHub Copilot CLI fired the first shot: 👉 Tightened access to flagship models 👉 Paused new subscriptions Translation? Compute is getting tight. Anthropic is testing limits — but the real story is what’s happening underneath the surface of the AI boom. Here’s the chain reaction 👇 Signal: compute constraints are real. Then 24 hours later… Claude Code access got restricted for Claude Pro subscription users. Upgrade path? 👉 Claude Max subscription Anthropic says it’s limited (~2% of new users), but the message is clear: AI demand is outpacing supply. AI doesn’t run on vibes — it runs on data centres, chips, and power. Two major players Two sudden access

Regarding the options market, a total volume of 55,400,989 contracts was traded, down 36% from the previous trading day. Ondas Holdings shares jumped 7.3% on Monday. Ondas announced its subsidiary 4M Defense received a $10 million order as part of a $50 million demining program for Israel’s eastern border. The contract represents the initial phase of a broader $1.7 billion Eastern Border Security Barrier initiative led by the Israeli Ministry of Defense.

$NVIDIA(NVDA)$ $Tesla Motors(TSLA)$  $Microsoft(MSFT)$  📊📈📊 Magnificent 7 Re-Accumulation Is Accelerating: Retail Led the Bottom, Institutions Are Now Re-Leveraging 📊📈📊 📊 The narrative says caution. The data says capital is already rotating back into risk. Retail never left the Magnificent 7. Now institutions are following, and they are doing it from reset positioning levels that still have room to expand. That is where asymmetric trends begin. 📈 J.P. Morgan flow data through March 2026 confirms persistent retail accumulation across the Magnificent 7, extending even into names like $PLTR. Cumulative flows highlight the scale of conviction: • $

$POET Technologies Inc(POET)$ $Lumentum(LITE)$  $COHERENT(COHR)$  📈📡⚡ POET Technologies Reclaims $10: Options Conviction, Short Thesis Failure, and the 2026 Revenue Inflection ⚡📡📈 📊 A Breakout Backed by Positioning, Not Noise $POET clearing the $10 level for the first time since 2022 is not merely technical momentum, it reflects a shift in market positioning and forward expectations. A ~+40% move in a single week, combined with a 10:1 call-to-put ratio, signals aggressive upside participation rather than passive retail chasing. The Bloomberg put/call data reinforces this regime. Sustained suppression in the ratio, punctuated by sharp spikes, i

Eyes on the prize—what’s your next move? 🧠📍Markets giving you signals or noise today?💥 Let’s compare notes and sharpen our edge.Today’s Highlights in Markets：Big news, big impact.More NewsTiger Community TOP10 TickersWeekly Five Key Areas: Macro, Singapore Stocks, Options, Futures, EarningsCovering five major market segments this week to help you stay ahead of market trends and plan your trades effectively!📈 Wednesday — Options Market Analyze options open interest and implied volatility to track short-term market movements.Regarding the options market, a total volume of 55,400,989 contracts was traded, down 36% from the previous trading day.Ondas Holdings shares jumped 7.3% on Mon

BUY CHEAP $UnitedHealth(UNH)$  

$Apple(AAPL)$    On April 20, $Apple (AAPL.US)$ An official major personnel change was announced – Tim Cook will step down as CEO on September 1, 2026, and transition to the role of Executive Chairman of the Board. His legendary 15-year tenure leading Apple is coming to an end. At the same time, John Ternus, Senior Vice President of Hardware Engineering with 25 years at Apple, will assume the role of CEO and join the board on the same day. This news quickly drew market attention, with Apple's after-hours stock price falling by about 0.6%, as the company's market cap had just surpassed the $4 trillion mark at the time of the announcement. Under Tim Cook’s 15-year leadership (2011-2026), Apple’s market cap soared

$Alphabet(GOOGL)$ $Amazon.com(AMZN)$  $Microsoft(MSFT)$  📊📉📊 AI Earnings Reacceleration Meets Valuation Compression: Scepticism Still Dominates the Narrative 📊📉📊 📊 The Bloomberg chart reinforces what the market is quietly signalling. Forward multiples across Alphabet Inc. ($GOOGL), Amazon ($AMZN), Microsoft ($MSFT) and Meta Platforms ($META) have been structurally compressing since mid-2023 despite one of the strongest earnings upgrade cycles in recent history. I’m looking at this through a purely fundamental lens. If this were a speculative AI bubble, price would be outrunning earnings. Instead, earnings are outrunning price. 📊 Current Valua

My stock in focus today is $Astera Labs, Inc.(ALAB)$ , which surged over 9% on the back of strong catalysts. The main driver was Amazon.com expanding its AI investment into Anthropic, with potential commitments up to $25 billion and massive long-term cloud spending. This directly strengthens demand visibility across the AI infrastructure stack, where Astera is a key connectivity player. This move feels more structural than speculative. As hyperscalers scale AI, data movement and interconnect become critical bottlenecks—exactly where Astera Labs Inc. is positioned. The price tar

Wall Street closed slightly lower today, but the action was anything but quiet — Tesla declined 2%, Intel dropped 4%, Apple jumped 1% after naming insider John Ternus as new CEO (with Cook moving to executive chairman), Marvell surged 6% on report of deal talks with Google to develop two AI chips, and USAR soared 13%. 😤 This selective rotation highlights the market’s focus on AI infrastructure and leadership transitions amid ongoing macro uncertainty. Amazon’s announcement of up to $25 billion investment in Anthropic as part of a $100 billion cloud deal added further AI cloud momentum, while Snap named Doug Hott as new CFO and Alaska Air pulled its 2026 profit forecast amid fuel cost uncertainty. The Tiger Daily highlights these moves as the key stories shaping sentiment, with the broader

$ServiceNow(NOW)$ is scheduled to report its fiscal Q1 2026 results tomorrow, Wednesday, April 22, 2026, after the market close. The stock enters this print under significant pressure, having declined roughly 35–47% year-to-date (depending on the recent swing lows around $96.66). This setup suggests that much of the "AI fatigue" and federal spending concern may already be priced in, creating a potential "relief rally" scenario if the numbers are simply "good enough." Key Estimates & Consensus Revenue: Consensus is $3.75B–$3.78B (up ~21% YoY). Adjusted EPS: Consensus is $0.96–$0.97 (up ~20-25% YoY). Subscription Revenue Guidance (Q1): Management previously guided to $3.65B–$3.67B. The fiscal Q4 2025 earnings report for ServiceNow (NOW), released

A King Meets His Reflection I’ve always found the market becomes most revealing when a company stops being judged on what it does and starts being judged on what it represents. $NVIDIA(NVDA)$ has reached that point. At nearly $5 trillion in market capitalisation, it now functions as a proxy for artificial intelligence and, by extension, the market’s confidence in future growth itself. That shift sounds subtle, but it changes how the stock behaves. Nvidia is no longer just analysed—it is interpreted. Nvidia has shifted from asset to narrative anchor And that’s where things become interesting. Because when a company turns symbolic, expectations tend to drift away from operational reality. Nvidia’s challenge in this second act is not proving it is ex

Intel Earnings Preview: Can AI CPU Momentum Offset Margin Pressure? $Intel(INTC)$   will report first quarter 2026 results after the market closes on Thursday, April 23. For investors, this quarter matters less because of absolute revenue scale and more because it should show whether Intel’s turnaround is finally translating into cleaner execution across CPUs, manufacturing, and margins.  Core Financial Indicators Revenue is expected to come in slightly above the midpoint of Intel's own guidance. In January, the company guided for first quarter revenue of $11.7 billion to $12.7 billion. The current analyst consensus of about $12.4 billion therefore assumes Intel can land modestly above the midpoint, he

UnitedHealth Earnings Preview: Can Cost Discipline Restore Confidence? $UnitedHealth(UNH)$   is scheduled to report first-quarter 2026 results before the market opens on April 21 and will host its earnings call at 8:00 a.m. ET. On the surface, this is a routine quarterly report. In reality, it looks much more like the market’s first full test of whether UnitedHealth’s 2026 recovery framework is actually holding. Investors are no longer asking whether the company can still grow. The real question now is whether medical costs are finally moving back under control, whether Optum can stop weighing on earnings quality, and whether full-year guidance still looks credible. Public earnings previews currently point t

So $Apple(AAPL)$ took a slide after Cook announced he will be resigning. I believe the next earnings will show positive results, but will be interested to see if the impact of this leadership change will offset the good news.